Cargando…
Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation
IgA Nephropathy (IgAN) is a common cause of end-stage kidney disease worldwide. Unfortunately, the exact pathogenesis of IgAN remains uncertain without any targeted therapy. While kidney transplantation remains the gold standard treatment for those with end-stage kidney disease from IgAN, recurrence...
Autores principales: | Sharma, Akhil, Hariharan, Sundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964927/ https://www.ncbi.nlm.nih.gov/pubmed/32047846 http://dx.doi.org/10.1097/TXD.0000000000000963 |
Ejemplares similares
-
Predictive Models for Recurrent Membranous Nephropathy After Kidney Transplantation
por: Chung, Edmund Y. M., et al.
Publicado: (2022) -
Kidney Transplant Outcomes After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: A Single-Center Experience
por: Sood, Puneet, et al.
Publicado: (2016) -
Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
por: Owoyemi, Itunu, et al.
Publicado: (2021) -
High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019) -
Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing
por: Kalluri, Hari V., et al.
Publicado: (2020)